Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
119,358,581
-
Total 13F shares
-
137,672,960
-
Share change
-
+2,706,529
-
Total reported value
-
$4,548,776,123
-
Put/Call ratio
-
31%
-
Price per share
-
$33.04
-
Number of holders
-
308
-
Value change
-
+$22,757,186
-
Number of buys
-
167
-
Number of sells
-
175
Institutional Holders of CYTOKINETICS INC - COMMON STOCK (CYTK) as of Q2 2025
As of 30 Jun 2025,
CYTOKINETICS INC - COMMON STOCK (CYTK) was held by
308 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
137,672,960 shares.
The largest 10 holders included
T. Rowe Price Investment Management, Inc., BlackRock, Inc., VANGUARD GROUP INC, FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, Deep Track Capital, LP, UBS Group AG, GEODE CAPITAL MANAGEMENT, LLC, and Vestal Point Capital, LP.
This page lists
308
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.